category guide

How to Choose a Defibrillator

April 30, 2026· 9 min read· AI-generated

How to Choose a Defibrillator

From public-access AEDs to hospital monitor/defibrillators — what procurement officers and biomedical engineers need to know before specifying, buying, or leasing.

What this is and who buys it

A defibrillator delivers a precisely calibrated electrical pulse through the chest wall to terminate life-threatening arrhythmias — most critically ventricular fibrillation (VF) and pulseless ventricular tachycardia. The device works by simultaneously depolarising a critical mass of cardiac muscle, allowing the heart's own conduction system to re-establish an organised rhythm. Without that intervention, every minute of untreated VF reduces survival probability by roughly 7–10%, which means device readiness is not a secondary concern — it is the primary procurement metric.

The buyer landscape is unusually broad for a single device category. Hospital procurement teams are typically sourcing manual monitor/defibrillators for crash carts, ICUs, operating rooms, and emergency departments — units that must support synchronized cardioversion, transcutaneous pacing, 12-lead ECG acquisition, and waveform documentation. Ambulatory surgery centers and dental practices generally need something in between: a semi-automatic AED with ECG display and a manual override accessible to ACLS-trained staff. At the far end of the spectrum, facility managers, school districts, corporate safety officers, and gym operators are deploying fully or semi-automatic AEDs for lay-rescuer use in public-access programs. Each of these contexts implies a different device class, regulatory pathway, and long-term support model.

What ties these buyers together is an underappreciated truth: the device itself is rarely the failure point in a cardiac arrest response. Field failures are most commonly traced to expired batteries or pads and missed periodic maintenance checks — not to hardware malfunction. That shifts the procurement calculus toward program management and consumable lifecycle planning from day one.

Key decision factors

Device class is the foundational choice. Public-access AEDs operate in semi-automatic mode — the device analyses the rhythm and prompts a lay user to press a shock button — or fully automatic mode, which delivers the shock without any user action. Hospital and ASC environments call for manual monitor/defibrillators that layer synchronized cardioversion and transcutaneous pacing on top of defibrillation, along with continuous patient monitoring. Conflating these two classes leads to either over-procurement (deploying expensive hospital units in a gym) or dangerous under-procurement (placing a basic AED where a clinician needs manual override).

Waveform and energy output should be non-negotiable items in your specification. Biphasic waveforms — which deliver current in two sequential directions — are now universally preferred over monophasic designs because they achieve equivalent defibrillation efficacy at lower delivered energy, reducing the risk of myocardial damage. Confirm that the unit supports escalating energy protocols up to 360 J for refractory VF cases; some entry-level AEDs cap at lower fixed-energy outputs that may be inadequate for certain patient populations.

Battery and pad shelf life directly determines your 8-year total cost of ownership. Battery replacement cycles typically run two to five years depending on manufacturer and usage; electrode pads generally expire every two to four years. For a fleet of twenty AEDs, consumable replacement costs over a decade can easily exceed the original hardware investment — yet this is routinely omitted from initial budget requests.

Self-test cadence and readiness indicators separate well-engineered AEDs from adequate ones. Some units perform dozens of automatic self-checks monthly, testing battery charge, pad connectivity, and internal circuitry, then signal a visible or audible alert when something fails. In a public-access program where no trained biomedical engineer is checking devices daily, this automated escalation is the primary safety net between inspections.

Environmental rating and ruggedization matters more than many buyers anticipate. An EMS or transport unit that will be carried on ambulances and helicopters needs to meet MIL-STD-810G testing standards for shock, vibration, and temperature extremes. A wall-mounted lobby AED in a climate-controlled office building does not — and paying for that ruggedization unnecessarily inflates cost.

CPR feedback and ancillary monitoring have become meaningful differentiators at the upper end of the market. Real-time CPR depth and rate coaching, end-tidal CO₂ monitoring via capnography modules, and post-event data export to quality-assurance platforms like CODE-STAT all contribute to resuscitation quality improvement programs that major health systems now require for TJC accreditation and AHA Get-With-The-Guidelines reporting.

Pediatric capability is frequently overlooked in mixed-population settings. For patients under 8 years of age or under 25 kg, standard adult energy delivery is inappropriate. Most AEDs address this through pediatric attenuator pads or a hardware key that reduces delivered energy — but you must verify this feature is present and that the pediatric accessories are in stock and within their expiration date.

What it costs

Published list pricing for defibrillators spans nearly an order of magnitude depending on device class and configuration, and street prices vary further based on contract vehicles, group purchasing organization (GPO) agreements, and refurbishment status. The ranges below reflect publicly available market pricing as of 2025–2026 S6 S7:

$1,100–$2,000 — Entry-level public-access AEDs. This band covers most semi- or fully-automatic AEDs intended for lay-rescuer deployment (e.g., HeartSine, Defibtech Lifeline, Philips HeartStart OnSite). Budget separately for wall cabinets, signage, and the first consumable replacement cycle.
$2,000–$5,000 — Professional AEDs with ECG display / manual override, or refurbished hospital monitor-defibrillators. ASCs and clinics with ACLS-trained staff typically land here. Refurbished LIFEPAK 20/20e and ZOLL M Series units appear in this range but require careful due-diligence on recertification documentation.
$5,000–$15,000+ — New hospital-grade monitor/defibrillators with pacing, SpO₂, and capnography. Units like the LIFEPAK 20e and ZOLL R Series sit in this band. Pricing for fully configured systems with capnography modules is not always publicly listed; request itemised quotes.

Common use cases

Defibrillator requirements differ enough across care settings that specifying a single device for an entire organisation is rarely appropriate. The four most common procurement contexts are:

Hospital crash carts, ICUs, ORs, and EDs: Manual monitor/defibrillators with 12-lead ECG, synchronized cardioversion, transcutaneous pacing, SpO₂, and capnography. Fleet standardisation on a single platform significantly simplifies operator training and PM scheduling.
EMS and inter-facility transport: Ruggedized, battery-redundant units with real-time telemetry to receiving facilities. MIL-STD-810G certification and a verified cold-temperature battery performance rating are minimum specifications.
Ambulatory surgery centers and dental/clinic settings: Semi-automatic AEDs with ECG display and manual override capability. ACLS-trained staff can use the manual mode; less-trained personnel fall back to guided AED operation.
Public-access programs (schools, airports, gyms, corporate campuses): Fully or semi-automatic AEDs with clear voice and visual prompts. Program management — pad/battery tracking, recall monitoring, medical director oversight — is as important as the hardware choice.

Regulatory and compliance

AEDs and their required accessories — batteries, pad electrodes, pediatric adapters, and hardware keys — are classified as FDA Class III devices requiring Premarket Approval (PMA) S1 S2. Accessories fall under 21 CFR 870.5310; importantly, accessories for non-FDA-approved AEDs may no longer be commercially available following a February 2022 regulatory deadline, making grey-market or non-cleared device purchases a supply-chain risk, not just a compliance risk S2. Manual defibrillators may be cleared through the 510(k) pathway. Before issuing a purchase order, verify both the device and its accessories appear in FDA's PMA database and the GUDID/AccessGUDID system via UDI lookup.

The governing performance and safety standard is ANSI/AAMI/IEC 60601-2-4, which specifies basic safety and essential performance requirements for cardiac defibrillators operating via external or internal electrodes; it supplements IEC 60601-1 (3rd edition, 2005) and does not apply to implantable devices, remote-control defibrillators, or standalone transcutaneous pacemakers S3. EMC compliance falls under IEC 60601-1-2 and alarm system requirements under IEC 60601-1-8. Biomedical inspection cadence is shaped by AAMI EQ56 and The Joint Commission standards, which typically translate to monthly readiness checks plus annual electrical safety and energy-output verification using a calibrated defibrillator analyzer. Any event data or patient identifiers stored on the device or transmitted wirelessly are subject to HIPAA and should be addressed in your data security review.

Service, training, and total cost of ownership

Acceptance testing at installation should verify that delivered energy output meets IEC 60601-2-4 tolerances — this requires a calibrated defibrillator analyzer, not a visual inspection. Operator training typically costs $300–$700 per session in blended or in-person formats and should cover both routine operation and the self-test/inspection protocol your biomedical team will use monthly. Monthly checks should at minimum confirm pad and battery expiration dates, review the self-test log, and document findings; annual PM should include a full electrical safety test and measured energy output at multiple joule settings.

Manufacturer warranties on new AEDs commonly run seven to eight years, but battery warranties may be pro-rated — a detail worth clarifying before signing. Useful service life is eight to ten years for AEDs and ten or more years for hospital monitor/defibrillators with consistent PM. For hospitals with credentialed clinical biomedical engineers and in-house analyzer equipment, self-performed PM is typically more economical than an OEM service contract. Clinics and ASCs with fewer than five units usually find OEM or third-party service contracts — budgeted at roughly 8–12% of capital cost annually — more practical than maintaining in-house capability. Verify the manufacturer's parts-availability commitment in writing; orphaned platforms create expensive mid-lifecycle replacement decisions.

Red flags to watch for

Any unit that cannot be cross-referenced to an active FDA PMA listing should be disqualified immediately — non-approved devices carry accessory supply-chain risk that can render the hardware unusable. Refurbished units offered without a documented defibrillator-analyzer calibration report and a warranty of at least one year deserve equivalent scrutiny; a 30–90 day warranty on life-safety equipment is commercially inadequate. Mixing biphasic and monophasic waveform devices across a single facility fleet complicates protocol training and creates confusion during an arrest. Finally, treat any vendor who quotes acquisition price as a proxy for total cost of ownership with scepticism — consumables, training, and program management frequently exceed the hardware cost over an eight-year cycle.

Questions to ask vendors

Provide the FDA PMA number (AED) or 510(k) K-number (manual defibrillator) and confirm current GUDID/UDI listing for the device and all accessories.
What is the documented warranty length on the device, battery, and electrode pads — and is the battery warranty pro-rated after year two?
What waveform is delivered, what is the maximum energy output into a 50 Ω test load, and what is the published charge time at maximum energy?
What parameters does the automated self-test check, on what schedule, and how are failed self-tests escalated (indicator light, audible alarm, network alert)?
Provide an itemised 8-year total cost of ownership estimate including pad replacements, battery replacements, and any software or data-connectivity subscription fees.
Is a loaner unit provided during depot repair, and what is the guaranteed repair turnaround time in writing?

Alternatives

The new-versus-refurbished decision involves a real tradeoff between acquisition cost and risk exposure. New AEDs are publicly listed in the $1,100–$15,000 range depending on class; refurbished units from reputable remanufacturers can reduce acquisition cost by 30–70%, but warranties typically drop to 90 days to one year versus five to eight years on new S6 S7. For life-safety equipment that must function on first use without warning, insist on documented OEM-specification recertification and a recent analyzer report before accepting a refurbished unit. Operating leases over three to five years can bundle consumable refreshes and recall management into a predictable operating expense — a meaningful advantage for multi-site programs that lack centralised biomedical support. Purchase wins on TCO past roughly year five assuming normal consumable costs. For portfolios of ten or more public-access AEDs, dedicated AED program management services that consolidate pad and battery tracking, recall notifications, and medical director oversight are worth evaluating as a cost centre distinct from the hardware decision itself.

Sources

Browse vendors in

Defibrillators

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.